Plain-English translation of NCT07630506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a form of B vitamin, can help improve symptoms in children with autism spectrum disorder. Some children with autism may have difficulty absorbing or using certain B vitamins, and researchers want to see if adding this supplement could make a difference. The study will compare the medication to a placebo (a dummy pill) to find out if it actually works.
Some children with autism have been found to have lower levels of certain B vitamins, and small studies suggest that supplementing with might help with some autism symptoms. This larger, carefully controlled trial will help doctors understand whether this treatment is truly helpful and safe.
You likely qualify if…
You likely don't qualify if…
Your child will visit the clinic and be randomly assigned to receive either the supplement or a placebo (a pill that looks identical but has no active ingredient) for 12 weeks. Neither you nor the study staff will know which one your child is getting during this first phase. After 12 weeks, all participants—including those who received the placebo—will receive the actual supplement for another 12 weeks so researchers can watch for longer-term effects. Throughout the study, you'll fill out questionnaires about your child's symptoms and behavior, and attend regular clinic visits.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Singapore